Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3309-3312

  Duong, Michel ^b   Simard, Marie ^b   Bergeron, Yves ^b   Ouellet, Nathalie ^b   Côté Richer, Mélanie ^b   Bergeron, Michel G ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HMR 3004;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; IMMUNOMODULATION; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SURVIVAL;

EID: 0031729422     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3309     Document Type: Article

References (29)

1. Agouridas, C., A. Bonnefoy, K. Braham, F. Collette, M. Guitton, A. Hochet, P. Mauvais, and J. F. Chantot. 1995. RU 004: uptake by phagocytes, intracellular bioactivity and other immunomodulatory effects, ahstr. F175. p. 102. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.
2. Agouridas, C., A. Bonnefoy, and J. F. Chantot, 1997. Antibacterial activity of RU 64004 (HMR3004), a novel ketolide derivative active against respiratory pathogens. Antimicrob. Agents Chemother. 41:2149-2158.
3. Bergeron, V., N. Ouellet, A. M. Deslauriers, M. Simard, M. Olivier, and M. G. Bergeron, 1998. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect. Immun. 66:912-922.
4. Dehoux, M. S., A. Boutten, J. Ostinelli, N. Seta, M. C. Dombret, B. Crestani, M. Deschenes, J. L. Trouillet, and M. Aubier. 1994. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 150:710-716.
5. Demling, R. H. 1988. The role of mediators in human ARDS. J. Crit. Care 3:56-72.
6. Ednie, L. M., S. K. Spangler, M. R. Jacobs, and P. C. Appelbaum. 1997. Susceptibilities of 228 penicillin- and crythromycin-susceptible and -resistant pneumoeocci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrob. Agents Chemother. 41:1033-1036.
7. Green, L. C., S. R. Tannenbaum, and P. Goldman. 1981. Nitrate synthesis in the germfree and conventional rat. Science 212:56-58.
8. Gross, S. S., and M. S. Wolin. 1995. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57:737-769.
9. Honda, J., A. Keisuke, O. Yasumitu, N. Sin, and O. Kotaro. 1995. Effects of macrolides on cytokine mRNA expression, ahstr. 3195. Can. J. Infect. Dis. 6(Suppl. C):423C.
10. Iino, Y., M. Toriyama, K. Kudo, Y. Natori, and A. Yuo. 1992. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor-alpha production by human monocytes in vitro. Ann. Otol. Rhinol. Laryngol. 101:16-20.
11. Jamjian, C., D. Biedenbach, and R. Jones. 1997. In vitro evaluation of a novel ketolide antimicrobial agent. RU-64004. Antimicrob. Agents Chemother. 41:454-459.
12. Labro, M. T. 1997. The prohost effect of antimicrobial agents as a predictor of clinical outcome. J. Chemother. 9(Suppl. 1):100-108.
13. Lukacs, N. W., and P. A. Ward. 1996. Inflammatory mediators, cytokines and adhesion molecules in pulmonary inflammation and injury. Adv. Immunol. 62:257-291.
14. Lyons, C. R. 1995. The role of nitric oxide in inflammation. Adv. Immunol. 60:323-355.
15. Morikawa, K., H. Watabe, M. Araake, and S. Morikawa. 1996. Modulatory effect of antibiotics on cytokine production by human mouocytes in vino. Antimicrob. Agents Chemother. 40:1366-1370.
16. Moussa, K., H. J. Michie, I. A. Cree, A. C. McCafferty, J. H. Winter, D. P. Dhillon, S. Stephens, and R. A. Brown. 1994. Phagocyte function and cvtokine production in community acquired pneumonia. Thorax 49:107-111.
17. Oda, H., J. Kadota, and K. Hara. 1994. Erythromycin inhibits neutrophil ehemotaxis in bronchoalveoli of diffuse panbronchiolitis. Chest 106:1116-1123.
18. Okubo, Y., J. Honda, K. Arikawa, and K. Oizumi. 1995. Macrolides reduce the expression of surface MAC-1 molecule on neutrophil, abstr. 3200. Can. J. Infect. Dis. 6(Suppl. C):424C.
19. Oppenheim, J., C. Zacharia, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory "intercrine" cvtokine factor-alpha. Annu. Rev. Immunol. 9:617-624.
20. Puren, A. J., C. Feldman, N. Savage, P. J. Becker, and C. Smith. 1995. Patterns of cytokine expression in community-acquired pneumonia. Chest 107:1342-1349.
21. Sibille, Y., and H. Reynolds. 1990. Macrophages and polymorphonuclear cells in lung defense and injury. Am. Rev. Respir. Dis. 141:471-5111.
22. Simpson, S. Q., R. Singh, and D. E. Bice. 1994. Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-alpha production by murine macrophages. Am. J. Respir. Cell Mol. Biol. 10: 284-289.
23. Sugita, K., and T. Nishimura. 1995. Effects of antimicrobial agents on chemolaxis of human polymorphonuclear neutrophils, abstr. 3203. Can. J. Infect. Dis. 6(Suppl. C):424C.
24. Takeshi, F., J. I. Kadota, R. Shirai, K. Kawakami, K. Iida, M. Kaseda, S. Kawamoto, S. Kohno, and K. Hara. 1995. Inhibitory effect of roxithromycin on interleukin-8 production by vitamin D3-induecd THP-1 cells, abstr. 3194. Can. J. Infect. Dis. 6(Suppl. C):423C.
25. Takeshita, K., I. Yamagashi, M. Harada, S. Otomo, T. Nakagawa, and Y. Mizushima. 1989. Immunological and antiinflammatory effects of clarithromycin: inhibition of IL-1 production of murine peritoneal macrophages. Drugs Exp. Clin. Res. 15:527-533.
26. Van Vlem, B., R. Vanholder, P. de Paepe, D. Vogelaers, and S. Ringoir. 1996. Immunomodulating effects of antibiotics: literature review. Infection 24:275-291.
27. Vazifeh, D., H. Abdelghaffar, and M. T. Labro. 1997. Cellular accumulation of the new kelolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob. Agents Chemother. 41: 2099-2107.
28. Wenisch, C., K. Parschalk, K. Zedtwitz-Liebenstein, A. Weihs, I. El Menyawi, and W. Graninger. 1996. Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by How cytometry. Antimicrob. Agents Chemother. 40:2039-2042.
29. Wright, C. E., D. Ress, and S. Mondaca. 1992. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26:48-57.